Matches in Wikidata for { <http://www.wikidata.org/entity/Q34550827> ?p ?o ?g. }
- Q34550827 description "2004 nî lūn-bûn" @default.
- Q34550827 description "2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած" @default.
- Q34550827 description "2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված" @default.
- Q34550827 description "2004年の論文" @default.
- Q34550827 description "2004年論文" @default.
- Q34550827 description "2004年論文" @default.
- Q34550827 description "2004年論文" @default.
- Q34550827 description "2004年論文" @default.
- Q34550827 description "2004年論文" @default.
- Q34550827 description "2004年论文" @default.
- Q34550827 description "2004年论文" @default.
- Q34550827 description "2004年论文" @default.
- Q34550827 description "2004年论文" @default.
- Q34550827 description "2004年论文" @default.
- Q34550827 description "2004年论文" @default.
- Q34550827 description "2004년 논문" @default.
- Q34550827 description "article científic" @default.
- Q34550827 description "article scientific" @default.
- Q34550827 description "article scientifique (publié 2004)" @default.
- Q34550827 description "articol științific" @default.
- Q34550827 description "articolo scientifico" @default.
- Q34550827 description "artigo científico (publicado na 2004)" @default.
- Q34550827 description "artigo científico (publicado na 2004)" @default.
- Q34550827 description "artigo científico" @default.
- Q34550827 description "artikull shkencor" @default.
- Q34550827 description "artikulong pang-agham" @default.
- Q34550827 description "artykuł naukowy" @default.
- Q34550827 description "artículo científico publicado en 2004" @default.
- Q34550827 description "artículu científicu espublizáu en 2004" @default.
- Q34550827 description "bilimsel makale" @default.
- Q34550827 description "bài báo khoa học" @default.
- Q34550827 description "mokslinis straipsnis" @default.
- Q34550827 description "naučni članak" @default.
- Q34550827 description "scienca artikolo" @default.
- Q34550827 description "scientific article" @default.
- Q34550827 description "teaduslik artikkel" @default.
- Q34550827 description "tieteellinen artikkeli" @default.
- Q34550827 description "tudományos cikk" @default.
- Q34550827 description "vedecký článok" @default.
- Q34550827 description "vetenskaplig artikel" @default.
- Q34550827 description "videnskabelig artikel (udgivet 2004)" @default.
- Q34550827 description "vitenskapelig artikkel" @default.
- Q34550827 description "vitskapeleg artikkel" @default.
- Q34550827 description "vědecký článek" @default.
- Q34550827 description "wetenschappelijk artikel" @default.
- Q34550827 description "wissenschaftlicher Artikel" @default.
- Q34550827 description "επιστημονικό άρθρο" @default.
- Q34550827 description "мақолаи илмӣ" @default.
- Q34550827 description "мақолаи илмӣ" @default.
- Q34550827 description "наукова стаття, опублікована у вересні 2004" @default.
- Q34550827 description "научна статия" @default.
- Q34550827 description "научная статья" @default.
- Q34550827 description "научни чланак" @default.
- Q34550827 description "научни чланак" @default.
- Q34550827 description "מאמר מדעי" @default.
- Q34550827 description "سائنسی مضمون" @default.
- Q34550827 description "مقالة علمية" @default.
- Q34550827 description "مقالهٔ علمی" @default.
- Q34550827 description "২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q34550827 description "บทความทางวิทยาศาสตร์" @default.
- Q34550827 description "სამეცნიერო სტატია" @default.
- Q34550827 name "Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate" @default.
- Q34550827 name "Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate" @default.
- Q34550827 name "Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate" @default.
- Q34550827 type Item @default.
- Q34550827 label "Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate" @default.
- Q34550827 label "Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate" @default.
- Q34550827 label "Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate" @default.
- Q34550827 prefLabel "Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate" @default.
- Q34550827 prefLabel "Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate" @default.
- Q34550827 prefLabel "Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate" @default.
- Q34550827 P1433 Q34550827-7FF55228-64F0-44C1-B074-BA537AD45527 @default.
- Q34550827 P1476 Q34550827-8602E5EB-CF0D-4529-988C-494274578300 @default.
- Q34550827 P2093 Q34550827-11038852-23E5-43AC-A321-331E534EFEA5 @default.
- Q34550827 P2093 Q34550827-1F0D66E5-BD43-4710-BA9E-2A44BD24944B @default.
- Q34550827 P2093 Q34550827-232A833E-7B51-4575-AE26-817297017DD4 @default.
- Q34550827 P2093 Q34550827-41537F28-6A44-453D-9FA6-4659913647CE @default.
- Q34550827 P2093 Q34550827-42781467-5FB6-4CFB-8672-22FDBDBEF6B4 @default.
- Q34550827 P2093 Q34550827-4EF15186-9BF1-42D5-B4AC-EC464918F2B2 @default.
- Q34550827 P2093 Q34550827-7B819D9C-60D6-44D8-A053-C01E8BDEC448 @default.
- Q34550827 P2093 Q34550827-8A218B92-2D1E-4A4D-9F20-486E996B496B @default.
- Q34550827 P2093 Q34550827-B9F8C6B7-43E5-47C4-8D03-9F46BD964A8C @default.
- Q34550827 P2093 Q34550827-C153991D-E9FC-4DE4-B49B-E37D31E1CBD2 @default.
- Q34550827 P304 Q34550827-76FDF295-59CD-4F0A-81BF-5A797F8AA1F2 @default.
- Q34550827 P31 Q34550827-62302C94-412E-4AC1-A1DF-445C5BEC3870 @default.
- Q34550827 P356 Q34550827-DB680AFD-2433-4161-8897-78D662ED46CE @default.
- Q34550827 P407 Q34550827-AC6D6B65-5615-4F2F-9F1E-43C7769C980F @default.
- Q34550827 P433 Q34550827-20F86993-1992-409E-B197-FB45734F4EF6 @default.
- Q34550827 P478 Q34550827-863C2AD3-A670-4521-AC62-2D634267C4B5 @default.
- Q34550827 P577 Q34550827-E15A9AAE-F144-4CFC-A9BB-1D6B961F9305 @default.
- Q34550827 P698 Q34550827-A4786F00-2D0C-436E-B697-40C24AC62994 @default.
- Q34550827 P921 Q34550827-3F8C725E-F5B2-47A9-BBB1-102E59F9A117 @default.
- Q34550827 P921 Q34550827-E76BFEBC-03E7-4387-9E63-247650A38A84 @default.
- Q34550827 P356 JCO.2004.12.082 @default.
- Q34550827 P698 15365074 @default.
- Q34550827 P1433 Q400292 @default.
- Q34550827 P1476 "Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate" @default.
- Q34550827 P2093 "Adele Morganti" @default.
- Q34550827 P2093 "Caio M Rocha Lima" @default.
- Q34550827 P2093 "G Mark Jeffrey" @default.